JESUS MELENDEZ: Open Payments
NPI 1063664647 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 87 payments from 23 companies in 2025. Trend: 2023 $1,770 · 2024 $1,875 · 2025 $1,530
Food & beverage: $1,530
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $299 |
| ABBVIE INC. | 20 | $213 |
| PFIZER INC. | 10 | $153 |
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| Abbott Laboratories | 5 | $106 |
| Dexcom, Inc. | 3 | $61 |
| Medtronic, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $47 |
Products named: VRAYLAR, Rybelsus, AIRSUPRA, FREESTYLE LIBRE 3, Ozempic, REXULTI, NURTEC ODT, Kerendia.
Industry payments across TN — which companies pay providers there.
